Tag: Applied Therapeutics

August 8, 2019

Applied Therapeutics Reports AT-007 SAD Data

Applied Therapeutics (NASDAQ:APLT) has announced it has finished the single ascending dose (SAD) healthy volunteer part of the Phase 1/2...
June 24, 2019

Applied Therapeutics Starts Phase 1/2 Study of AT-007

Applied Therapeutics (NASAQ:APLT) has announced it has started its Phase 1/2 study of AT-007 in galactosemia. As quoted in the...